Cell Signaling Technology (CST) was introducing new banner ads on nature.com to increase awareness of the CST brand as well as their XP line of antibodies. CST was interested in measuring the brand impact of their new campaign on their customer base — scientists using antibodies in their research.
To target their customer base CST scheduled leaderboard and skyscraper banner ads on the Nature, Nature Reviews Drug Discovery, and Nature Reviews Cancer sites.
The NPG Market Research Team developed a online campaign effectiveness study with robust methodology customized to CST’s objectives. Prior to CST’s campaign, we established critical benchmarks such as brand awareness, usage, favorability, and purchase intent. During the course of the CST campaign, we monitored changes in these metrics and measured prompted recall of the CST campaign as well as perceived appeal, information value, and verbatim feedback on CST’s banner creative.
A pre-campaign survey was delivered using banner ads on the same nature.com pages where CST’s campaign was scheduled to appear. A follow-up survey was delivered during the course of CST’s campaign via banner ads which were only shown to individuals who had previously been exposed to a CST banner ad. Both surveys included an initial screening question to ensure respondents were limited to scientists using antibodies and therefore appropriate to CST’s customer base. This approach allowed us to compare representative samples of CST’s customer base before and after exposure to their banner campaign.